Literature DB >> 8719207

B cells and T-lymphocyte subsets of the head-associated lymphoid tissues of the chicken.

D M Maslak1, D L Reynolds.   

Abstract

The head-associated lymphoid tissues of the chicken, composed of the harderian gland and the conjunctiva-associated lymphoid tissue (CALT), were studied to determine whether changes occurred in lymphocyte subpopulations as chickens age from 1 week to 8 weeks. The B cells and subpopulations of T-lymphocytes of the head-associated lymphoid tissues were identified using in situ immunohistochemical staining. Monoclonal antibodies specific for various lymphocyte surface antigens were used. The concentration of T-lymphocytes, particularly CD3+ and CD4+ cells, within the harderian gland increased with age, whereas the concentration of B cells remained the same. B-lymphocytes were observed within the germinal centers of the CALT of 4-week-old birds. The T-lymphocytes within the CALT surrounded the B-cell-rich germinal centers. CD3+ T-lymphocytes were the predominant cell population in all age groups examined. Increasing concentrations of CD3+, CD4+, and CD8+ T-lymphocytes were observed within the CALT as chicks developed from 1 week to 4 weeks of age. Finally, no changes were observed in lymphocyte populations within the CALT as chicks developed from 4 weeks to 8 weeks of age.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8719207

Source DB:  PubMed          Journal:  Avian Dis        ISSN: 0005-2086            Impact factor:   1.577


  2 in total

1.  Comparative Protective Efficacies of Novel Avian Paramyxovirus-Vectored Vaccines against Virulent Infectious Bronchitis Virus in Chickens.

Authors:  Edris Shirvani; Siba K Samal
Journal:  Viruses       Date:  2020-06-28       Impact factor: 5.048

2.  Age-dependent immune responses and immune protection after avian coronavirus vaccination.

Authors:  Frederik W van Ginkel; Justin Padgett; Gisela Martinez-Romero; Matthew S Miller; Kellye S Joiner; Stephen L Gulley
Journal:  Vaccine       Date:  2015-04-21       Impact factor: 3.641

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.